Socioeconomic Status and Risk of Diabetes-related Mortality in the U.S
Overview
Authors
Affiliations
Objective: We examined disparities in diabetes-related mortality for socioeconomic status (SES) groups in nationally representative U.S. samples.
Methods: We analyzed National Health Interview Survey respondents linked to their death records and included those eligible for mortality follow-up who were aged 25 years and older at the time of interview and not missing information on covariates (n=527,426). We measured SES by education and family income. There were 5,613 diabetes-related deaths.
Results: Having less than a high school education was associated with a twofold higher mortality from diabetes, after controlling for age, gender, race/ethnicity, marital status, and body mass index, compared with adults with a college degree or higher education level (relative hazard [RH] = 2.05, 95% confidence interval [CI] 1.78, 2.35). Having a family income below poverty level was associated with a twofold higher mortality after adjustments compared with adults with the highest family incomes (RH=2.41, 95% CI 2.05, 2.84). Approximately one-quarter of the excess risk among those in the lowest SES categories was explained by adjusting for potential confounders.
Conclusion: Findings from this nationally representative cohort demonstrate a socioeconomic gradient in diabetes-related mortality, with both education and income being important determinants of the risk of death.
Torabipour A, Karimi S, Amini-Rarani M, Gharacheh L BMC Health Serv Res. 2025; 25(1):328.
PMID: 40033328 PMC: 11874842. DOI: 10.1186/s12913-025-12222-w.
Golden F, Tran J, Wong N Am J Prev Cardiol. 2025; 21:100939.
PMID: 39990934 PMC: 11846931. DOI: 10.1016/j.ajpc.2025.100939.
The impact of social deprivation on development and progression of diabetic kidney disease.
Casey C, Buckley C, Kearney P, Griffin M, Dinneen S, Griffin T HRB Open Res. 2024; 7:53.
PMID: 39301450 PMC: 11411243. DOI: 10.12688/hrbopenres.13941.1.
Yamaoka T, Sugiyama T, Ihana-Sugiyama N, Kimura A, Yamamoto K, Imai K J Diabetes Investig. 2024; 15(11):1684-1695.
PMID: 39264346 PMC: 11527804. DOI: 10.1111/jdi.14301.
Continuous Glucose Monitor: Reclaiming Type 2 Diabetes Self-efficacy and Mitigating Disparities.
Ni K, Tampe C, Sol K, Cervantes L, Pereira R J Endocr Soc. 2024; 8(8):bvae125.
PMID: 38974988 PMC: 11223994. DOI: 10.1210/jendso/bvae125.